 BRIDGEWATER, N.J.--BUSINESS WIRE--Amneal Pharmaceuticals, Inc. NYSE: AMRX the Company announced its results today for the third quarter ended September 30, 2020. Amneal delivered another strong quarter, providing further evidence that our Amneal 2.0 strategy is positioning the company for sustained growth, said Chirag and Chintu Patel, Co-Chief Executive Officers. While the COVID pandemic continues to affect some aspects of the business, we continue to focus on execution, improving t 